Personnaliser

OK

Informations importantes : Arrêt du Club R (13 août) et Cessation d'Activité (30 septembre)

En savoir plus.

RX for Hope - David Tabatsky

Note : 0

0 avis
  • Soyez le premier à donner un avis

64,51 €

Produit Neuf

  • Ou 16,13 € /mois

    • Livraison à 0,01 €
    • Livré entre le 21 août et le 7 septembre
    Voir les modes de livraison

    RiaChristie

    PRO Vendeur favori

    4,9/5 sur + de 1 000 ventes

    Brand new, In English, Fast shipping from London, UK; Tout neuf, en anglais, expédition rapide depuis Londres, Royaume-Uni;ria9781538101605_dbm

    Publicité
     
    Vous avez choisi le retrait chez le vendeur à
    • Payez directement sur Rakuten (CB, PayPal, 4xCB...)
    • Récupérez le produit directement chez le vendeur
    • Rakuten vous rembourse en cas de problème

    Gratuit et sans engagement

    Félicitations !

    Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !

    En savoir plus

    Retour

    Horaires

        Note :


        Avis sur Rx For Hope de David Tabatsky Format Relié  - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire

        Note : 0 0 avis sur Rx For Hope de David Tabatsky Format Relié  - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire

        Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.


        Présentation Rx For Hope de David Tabatsky Format Relié

         - Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire

        Livre Médecine, Pharmacie, Paramédical, Médecine vétérinaire - David Tabatsky - 01/10/2018 - Relié - Langue : Anglais

        . .

      • Auteur(s) : David Tabatsky - Nick Chen
      • Editeur : Bloomsbury Academic
      • Langue : Anglais
      • Parution : 01/10/2018
      • Format : Moyen, de 350g à 1kg
      • Nombre de pages : 208
      • Expédition : 458
      • Dimensions : 26.4 x 15.5 x 2.0
      • ISBN : 9781538101605



      • Résumé :

        In our current era of rapidly developing cancer drugs and therapies, we also see improvement of cancer treatment outcomes stagnating when it comes to determining quality of life or long-term survival. This is because while new treatments are making small incremental progress in outcomes, most cancer patients still depend on conventional methods that are both toxic and ineffective. While new cancer drugs are becoming more precise or targeted, less attention is being paid to the overall health and wellbeing of the patient, which we propose is essential for long-term cancer control and improving a patient's quality of life.
        Rx for Hope, backed by rigorous science and real-life patient cases, calls for an urgent reevaluation of the current conventional approach to cancer treatments and encourages a progressive treatment model combining metronomic low-dose chemotherapy with complementary integrative medicine. Along with new, breakthrough immunotherapy drugs, these treatments can potentially create a response powerful enough to not only eradicate the presence of cancer but also to prevent it from returning.
        Because every 23 seconds someone in America is diagnosed with cancer, the number of people affected is growing rapidly. The American Cancer Society estimates that nearly two million new patients will need treatment in the coming year. Judging by current trends and methods of treatment, far too many of these people will be treated without the benefits of low-dose chemotherapy, and even less will enjoy the positive impact of immune-supportive complementary integrative medicine. Rx for Hope offers insight into a powerful way of treating cancer that patients and doctors can implement immediately for optimal results.

        ...

        Biographie:
        Nick Chen, MD, PhD, is the founder and medical director of The Seattle Integrative Cancer Center in Seattle, Washington. He is a board-certified medical oncologist and internist and a member of the American Society of Clinical Oncologists (ASCO) and the International Society of Integrative Oncology (SIO). He is a pioneer in the clinical application of metronomic low-dose chemotherapy and integrative oncology in the management of advanced cancers. Dr. Chen also has trained and practiced medicine on three different continents, which has afforded him extensive knowledge of different treatment models, most of which he incorporates into his practice....

        Sommaire:

        Nick Chen, MD, PhD, is the founder and medical director of The Seattle Integrative Cancer Center in Seattle, Washington. He is a board-certified medical oncologist and internist and a member of the American Society of Clinical Oncologists (ASCO) and the International Society of Integrative Oncology (SIO). He is a pioneer in the clinical application of metronomic low-dose chemotherapy and integrative oncology in the management of advanced cancers. Dr. Chen also has trained and practiced medicine on three different continents, which has afforded him extensive knowledge of different treatment models, most of which he incorporates into his practice.

        David Tabatsky is a writer, editor, teacher, and performing artist. His publications include Reimagining Women's Cancers: The Celebrity Diagnosis Guide to Personalized Treatment and Prevention (2016), coauthored with Michele Berman and Mark Boguski...

        Détails de conformité du produit

        Consulter les détails de conformité de ce produit (

        Personne responsable dans l'UE

        )
        Le choixNeuf et occasion
        Le service clientsÀ votre écoute
        LinkedinFacebookTwitterInstagramYoutubePinterestTiktok
        visavisa
        mastercardmastercard
        klarnaklarna
        paypalpaypal
        floafloa
        americanexpressamericanexpress
        Rakuten Logo
        • Rakuten Kobo
        • Rakuten TV
        • Rakuten Viber
        • Rakuten Viki
        • Plus de services
        • À propos de Rakuten
        Rakuten.com